DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158102. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 14,036,590 | $22,459,000 | 2.27% |
| Broadfin Capital, LLC | 15,320,200 | $24,512,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 1,228,354 | $1,965,000 | 0.58% |
| Polar Capital LLP | 10,946,861 | $17,508,000 | 0.37% |
| Amici Capital, LLC | 4,876,100 | $7,802,000 | 0.25% |
| Bain Capital Public Equity Management, LLC | 5,274,936 | $8,440,000 | 0.20% |
| FEDERATED HERMES, INC. | 34,115,000 | $54,584,000 | 0.17% |
| CLOUGH CAPITAL PARTNERS L P | 2,680,700 | $4,289,000 | 0.14% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 13,668,111 | $21,869,000 | 0.13% |
| HOWARD HUGHES MEDICAL INSTITUTE | 433,557 | $694,000 | 0.12% |